Indications, Mechanism of Action, Adverse Effects, Contraindications Toxicity of Ciproflaxacin

Ciprofloxacin is an antibiotic belonging to the fluoroquinolone class that is used to treat bacterial infections, specifically pneumonia and urinary tract infections. The FDA has approved ciprofloxacin for the treatment of gastrointestinal infections, lower respiratory tract infections, anthrax, plague, salmonellosis, skin, bone, joint infections, prostatitis, typhoid fever, and urinary tract infections. Additionally, patients with mixed infections or those with risk factors for Gram-negative infections can benefit from ciprofloxacin. In order to effectively manage patients' infectious infections, members of the interprofessional team must evaluate the indications, coverage, contraindications, and adverse event profile of ciprofloxacin, a broad-spectrum quinolone antibiotic.